Xiaoping Xu
Impact in
- Biomaterials top 5%
- Magnesium Alloys: Properties and Applications
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
- Oncology 36
- Peptidase Inhibition and Analysis 14
-
- Radiopharmaceutical Chemistry and Applications 23
- Medical Imaging Techniques and Applications 11
- Co-authors
- Shaoli Song (34 shared papers)Zongbin Liu (2 shared papers)Hongtao Feng (2 shared papers)Fei Huang (2 shared papers)Yan Chen (2 shared papers)Weiliang Shu (2 shared papers)Yuanqing Zhang (10 shared papers)Silong Hu (17 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (9 papers)Annals of Hematology (5 papers)PLoS ONE (3 papers)Blood (3 papers)Molecular Biology Reports (3 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Xiaoping Xu
181 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 156
- Biomaterials 385
- Oncology 603
- Cancer Research 278
- Radiology, Nuclear Medicine and Imaging 371
- Immunology and Allergy 72
Countries citing papers authored by Xiaoping Xu
This map shows the geographic impact of Xiaoping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Xu more than expected).
Fields of papers citing papers by Xiaoping Xu
This network shows the impact of papers produced by Xiaoping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Xu. The network helps show where Xiaoping Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 184 | |
| 2 | 2001 | 181 | |
| 3 | 2004 | 115 | |
| 4 | 2010 | 93 | |
| 5 | 2013 | 90 | |
| 6 | 2013 | 89 | |
| 7 | 2013 | 86 | |
| 8 | 2001 | 81 | |
| 9 | 2014 | 68 | |
| 10 | 2021 | 63 | |
| 11 | 2022 | 57 | |
| 12 | 2013 | 57 | |
| 13 | 2017 | 53 | |
| 14 | 2000 | 53 | |
| 15 | 2021 | 53 | |
| 16 | 2013 | 53 | |
| 17 | 2019 | 50 | |
| 18 | 2017 | 47 | |
| 19 | 2021 | 45 | |
| 20 | 2022 | 44 |
About Xiaoping Xu
Xiaoping Xu is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Pulmonary and Respiratory Medicine and Surgery, having authored 194 papers that have together received 3.1k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (23 papers), Peptidase Inhibition and Analysis (14 papers), Acute Myeloid Leukemia Research (13 papers), Protease and Inhibitor Mechanisms (12 papers), Medical Imaging Techniques and Applications (11 papers), Prostate Cancer Treatment and Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Control Systems and Identification (9 papers). The work is most often cited by research in Biomaterials (385 citations), Oncology (603 citations), Cancer Research (278 citations), Radiology, Nuclear Medicine and Imaging (371 citations) and Immunology and Allergy (72 citations). Xiaoping Xu has collaborated with scholars based in China, United States and France. Frequent co-authors include Shaoli Song, Zongbin Liu, Hongtao Feng, Fei Huang, Yan Chen, Weiliang Shu, Yuanqing Zhang, Silong Hu, Bobin Chen and Wenjiang Ding. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Annals of Hematology, PLoS ONE, Blood and Molecular Biology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.